Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Curia Unveils Brand Update | Contract Pharma
Breaking News

Curia Unveils Brand Update

Introduces refined corporate messaging and a new brand hierarchy.

Curia, a contract research, development and manufacturing organization, has unveiled its refreshed brand. The update introduces refined corporate messaging and a new brand hierarchy, highlighting the breadth of Curia’s CDMO capabilities across small molecules, generic APIs and biologics.
 
“This refresh reflects our unwavering commitment to being a trusted ally to our customers,” said Philip Macnabb, CEO of Curia. “Curia has decades of experience in this industry, and we have continually broadened our capabilities to meet the needs of our customers. Our new brand identity clearly communicates not just our offerings, but the unique level of expertise and collaboration we bring as we work to noble purpose to improve patients’ lives.”   
 
The brand refresh includes:
 
Three distinct commercial service logos – Curia has established brand logos for each of its three key service offerings across small molecules, generic APIs and biologics.
Revamped website –The evolved design improves the user experience for clients and prospects.
 
Curia began as AMRI more than 30 years ago with a focus on small molecules, and over time, expanded to offer a blend of global resources and scientific expertise. In 2021, AMRI rebranded as Curia and broadened its capabilities to include biologics with the acquisition of LakePharma and Integrity Bio. This next evolution of its brand strategically highlights Curia’s strengths as a full-service CDMO across modalities.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters